Hsien-Tai Chiu | Bio-Organic Chemistry | Best Researcher Award

Prof. Dr. Hsien-Tai Chiu | Bio-Organic Chemistry | Best Researcher Award

Associate Professor | National Cheng Kung University | Taiwan

Prof. Dr. Hsien-Tai Chiu is an Associate Professor in the Department of Chemistry at National Cheng Kung University (NCKU), Taiwan. He is widely recognized for his interdisciplinary expertise in drug discovery, biotechnology, chemical biology, and natural product biosynthesis. His academic and research leadership has bridged gaps between traditional and modern medical sciences, integrating fields such as artificial intelligence, bioinformatics, structural biology, enzymology, and biochemical engineering. As the founder and chairman of the Asia-Pacific BT&D² Alliance (APBA), Prof. Chiu leads a large-scale international collaborative network involving researchers from multiple countries, aiming to advance drug, nutraceutical, and cosmeceutical development for societal benefit.

Professional Profile

Scopus

Education

Prof. Chiu obtained his Ph.D. in Chemistry with a specialization in organic and synthetic methodologies. His academic foundation is solidly rooted in the chemical sciences, and his research training spans multiple leading institutions in Taiwan. He has been involved in notable projects focused on organic synthesis, particularly reactions involving heteroaromatic systems and molecular rearrangements.

Experience

Prof. Chiu holds several leadership positions, both nationally and internationally. He serves as the leader and project coordinator of the Taiwan BT&D² team at NCKU, where he supervises a multidisciplinary group of scientists and clinicians. He has also been a principal investigator and coordinator for key research initiatives under the SATU Joint Research Scheme, facilitating academic, industrial, and educational collaborations between Taiwan and other Southeast Asian countries. In addition, he manages various international talent exchange programs and joint research efforts, promoting cross-border innovation and academic synergy.

Research Interests

His research primarily centers on the discovery and development of pharmaceuticals, nutraceuticals, and healthcare products using a multi-platform approach. He has established an AI-integrated R&D framework that incorporates bioinformatics for disease target identification, cheminformatics for compound screening, virtual screening tools, and environmentally friendly chemical modification techniques. These platforms support the development of novel bioactive compounds and healthcare formulas with enhanced safety, potency, and efficacy. His team emphasizes the fusion of traditional Chinese medicine knowledge with modern scientific principles, fostering a holistic and innovative research culture.

Honors

Prof. Chiu has received several prestigious awards for his teaching excellence and commitment to student development. He has been recognized for his outstanding teaching performance at top Taiwanese universities. His student evaluations consistently reflect high satisfaction across both undergraduate and graduate levels. These accolades underscore his ability to inspire students while maintaining research excellence.

Top Noted Publications

Exploration of the anti-SARS-CoV-2 potential and expected mechanisms of small molecules from Antrodia cinnamomea by BT&D2 drug-targeting analysis – Bioorganic Chemistry, 2025

In situ tailoring of carbon dots-metal ferrite nanohybrid as multipurpose marker agent of HeLa cancer cells – 4 citations, Journal of Materials Research, 2022

Conclusion

Prof. Dr. Hsien-Tai Chiu exemplifies the qualities of an academic leader who bridges disciplines and transcends traditional boundaries. His contributions to pharmaceutical science, coupled with his active role in international research collaboration, demonstrate his dedication to improving global healthcare. Through innovative research platforms, educational mentorship, and strategic global engagement, he continues to pave the way for future advancements in drug discovery and biotechnology.

Dr Zu-Chian Chiang | Biological macromolecules | Best Researcher Award |

Dr. Zu-Chian Chiang | Biological macromolecules | Best Researcher Award | 

Postdoctoral Fellow, at Fujian Normal University ,China

Dr. Zu-Chian Chiang (蔣祖搴), Ph.D., is a dedicated postdoctoral researcher currently working at the Biomedical Research Center of Southern China, Fujian Normal University, Qishan Campus, Fuzhou, China. With a strong academic and research foundation rooted in Taiwan, Dr. Chiang has developed expertise in biomedical sciences, materials chemistry, and clinical applications of advanced therapeutic technologies. He has worked with prestigious institutions such as Academia Sinica and National Taiwan University Hospital, contributing significantly to translational medicine, particularly in targeted cancer therapy and regenerative medicine. His collaborative and cross-disciplinary approach reflects a deep commitment to scientific advancement and public health.

Professional Profile

Scopus

Education 🎓

Dr. Chiang earned his Ph.D. in Materials and Chemical Engineering from the College of Engineering and Science at National United University, Taiwan (2008–2014), where he also served as a teaching assistant across various chemistry and engineering courses. He completed his M.S. in Chemistry at Tunghai University, Taiwan (2005–2007), laying the foundation for his specialization in organic chemistry and material science. His academic path has been enriched by mentorship from notable scholars such as Prof. An-Chong Chao and Prof. Feng-Di Lung.

Experience 👩‍

Dr. Chiang has over a decade of research experience across Taiwan and China. His postdoctoral journey began at the Clinical Trial Center of National Taiwan University Hospital, followed by appointments at Academia Sinica’s Institute of Biological Chemistry under the Taiwan Protein Project and Translational Innovation programs. Since 2019, he has been a postdoctoral fellow at Fujian Normal University, collaborating with Prof. Qi Chen. He also brings a strong teaching background, having served as a teaching and lab assistant in various chemistry and engineering courses during his graduate studies.

Research Interests 🔬

Dr. Chiang’s research centers on the development of functional peptides and biopolymeric complexes for cancer research and bone tissue engineering. He specializes in cutting-edge areas such as Antibody-Drug Conjugates (ADCs) for targeted cancer therapy, specific aptamers used as molecular agonists or antagonists, and the synthesis of multifunctional biomaterials for regenerative medicine. His interdisciplinary work bridges the gap between chemical engineering and biomedical applications, aiming to design smarter and more effective therapeutic strategies.

Awards 🏆

Dr. Chiang has been recognized for his excellence with several prestigious awards, including the 2020 Science and Technology Commissioner of Quanzhou (Fujian Province) and the 3rd Biotech Elite Training Reserve Program Award by the Executive Yuan, Taiwan. Other accolades include the Chung Hwa Rotary Doctoral Program Award (2012), the Outstanding Doctoral Scholarship at National United University (2010), and the Master’s Program Scholarship from the Hunan Fellow Association (2007). His leadership is also recognized by Rotary International through various honors and leadership roles.

Top Noted Publications 📚

Dr. Chiang has authored and co-authored several impactful publications in international journals. His recent works include:

Development of 7DC-DM1, a CD47-targeting ADC with anti-tumor effects (IJ Biological Macromolecules, 2025).

Immuno-enhancement in lung cancer therapy via thalidomide and anti-PD-1 antibodies (Current Pharmaceutical Biotechnology, 2024).

CD47-specific ADCs for NSCLC treatment, demonstrating strong preclinical efficacy (Frontiers in Oncology, 2022).

Conclusion

Dr. Zu-Chian Chiang is a highly accomplished and promising researcher in the biomedical sciences, with a proven track record of impactful research, academic excellence, and leadership. His interdisciplinary expertise, from molecular synthesis to clinical trial collaboration, positions him as an outstanding candidate for any Best Researcher Award. With his continued contributions to science and society, Dr. Chiang exemplifies the qualities of innovation, dedication, and global impact.